FDA News Digest
June 11, 2007
__________________________________________
IN
THIS WEEK'S ISSUE
»
News
-- Web Pages Give Background on Newly Approved Medical Devices
-- 'FDA Patient Safety News' Video Available Online and as Podcast
» Recalls/Safety Alerts
» Congressional Testimony
» Question of the Week
__________________________________________
FDA has posted the latest edition of "FDA Patient Safety News," a free Web-based video news program. Aimed primarily at health professionals, the program features information on new drugs, biologics, and medical devices, as well as FDA safety notifications and product recalls.
-- To access Podcast: http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/psn/podcast.cfm
To view an archive of past FDA news releases, go to
To access the RSS feed of FDA news releases, go
to
http://www.fda.gov/bbs/topics/news/rssPress.xml.
[What is an RSS feed? See http://www.fda.gov/bbs/topics/news/newsfeeds.html.]
___________________________________________
RECALLS/SAFETY
ALERTS
For a list of recalls, market withdrawals, and safety
alerts involving
FDA-regulated
products from the past 60 days, go to http://www.fda.gov/opacom/7alerts.html.
To access the RSS feed of FDA recalls information, go
to
http://www.fda.gov/oc/po/firmrecalls/rssRecalls.xml
[What is an RSS feed? See http://www.fda.gov/bbs/topics/news/newsfeeds.html.]
_____________________________________________
CONGRESSIONAL TESTIMONY
June 6 -- FDA Commissioner Andrew C. von Eschenbach, M.D., appeared before the House Committee on Oversight and Government Reform
Subject: Type 2 diabetes drug Avandia
http://www.fda.gov/ola/2007/Avandia060607.html
To
view an archive of past testimony by FDA officials, go to
http://www.fda.gov/ola/listing.html
_____________________________________________
June 12-13 -- Public hearing to obtain feedback on FDA's Medication Guide program
Location: Washington, D.C.
http://www.fda.gov/bbs/topics/NEWS/2007/NEW01606.html
June 13 -- Endocrinologic and Metabolic Drugs Advisory Committee
Under discussion: pending application for a drug treatment for obesity
Location: Silver Spring, Md.
http://www.fda.gov/OHRMS/DOCKETS/98fr/E7-5506.htm
June 14 -- FDA Science Board
Under discussion: food protection, melamine, antibiotic resistance
Location: Gaithersburg, Md.
http://www.fda.gov/bbs/topics/NEWS/2007/NEW01649.html
June 27 -- Pediatric Oncology Subcommittee of the Oncologic Drugs Advisory Committee
Under discussion: oncology products granted pediatric exclusivity under the Best Pharmaceuticals for Children Act
Location: Rockville, Md.
http://www.fda.gov/OHRMS/DOCKETS/98fr/E7-8656.htm
June 27 -- Circulatory System Devices Panel of the Medical Devices Advisory Committee
Under discussion: pending application for a medical device that treats atrial flutter
Location: Gaithersburg, Md.
http://www.fda.gov/OHRMS/DOCKETS/98fr/E7-9054.htm
For a complete list of FDA meetings, seminars, and other public events, go to
http://www.fda.gov/opacom/hpmeetings.html.
Who
performs liposuction and where is it performed?
Many liposuction surgeries -- procedures intended to remove fat deposits and shape the body -- are performed by plastic surgeons or dermatologists. Any licensed physician may perform liposuction. While professional societies may recommend training before performing liposuction surgery, no standardized training is required. As a result, there will be differences in experience and training in physicians performing liposuction.
You
can ask your physician to tell you whether he or she has had specialized
training to do liposuction or has
successfully done liposuction before. But remember, even the best
screened patients under the care of the best trained and experienced physicians
may experience complications as a result of liposuction.
Liposuction may be performed in a doctor's office, surgical center, or hospital. Because liposuction is a surgical procedure, it is important that it be performed in a clean environment. Emergencies may arise during any surgery and access to emergency medical equipment or a nearby hospital emergency room is important.
Thanks for subscribing to FDA News Digest.
Comments about FDA News Digest?
Send an e-mail to fdanewsdigest@xxxxxxxxxv.
To subscribe to or
unsubscribe from this list, go to
http://list.nih.gov/cgi-bin/wa?SUBED1=fda-newsdigest-l&A=1.